skip to primary navigationskip to content

GeneAdviser partners with Birmingham Women’s Hospital to make personalised medicine more accessible

last modified Sep 29, 2016 10:46 AM
The largest genetics laboratory in the NHS brings to the platform their solid tumour sequencing, enabling clinicians to give an individual approach to their patients, tailored to their tumour’s genetic makeup.
GeneAdviser partners with Birmingham Women’s Hospital to make personalised medicine more accessible

 GeneAdvisor's CEO Jelena Aleksic (left) and CTO Robert Stojnic (right)

GeneAdviser is bringing the expertise of Birmingham Women’s Hospital to their ordering platform, where healthcare professionals can now order tests for genetic sequencing of tumour samples, screening for those changes in the tumour that may require clinical action.

Each tumour has a different genetic makeup, which makes it react to therapies very differently. By analysing and monitoring the presence of genetic sequences in a tumour, patients can be prescribed more targeted treatment and screening.

Dr Jelena Aleksic, GeneAdviser’s CEO, commented: “Birmingham Women’s Hospital combines outstanding and comprehensive genetics research and clinical expertise, making it an internationally renowned clinical laboratory. We are delighted to make their excellent genetic testing more accessible to doctors worldwide, helping them provide better care for their patients.”

Professor Michael Griffiths, the Birmingham Women’s Hospital Genetics Laboratory Director, added: "We are excited to join forces with GeneAdviser to facilitate worldwide access to our genetic test portfolio.  As the largest NHS genetics laboratory we already work closely with clinicians across the UK and internationally, and GeneAdviser will allow them to easily order the genetic  tests they need for their patients, whilst streamlining administrative processes for our staff."

Their partnership also expands beyond solid tumour sequencing, bringing forward a selection of high quality genetic tests in oncology and other medical specialties. Other tests from Birmingham Women’s Hospital include their Lucina NIPT (non invasive prenatal testing), a highly accurate genetic prenatal testing that screens for trisomies such as Down syndrome using a single maternal blood sample.

RSS Feed Latest news

EnXray Raises £2.3 Million to Fund Commercial Expansion

Apr 13, 2017

Funding for ground breaking Low Energy X-ray (LEXR) sterilisation machine.

Exciting Times for the Simprints Team

Mar 30, 2017

Making waves in social entrepreneurship and the Women Startup Challenge

A Conversation with Europe’s Leading Entrepreneurs and Investors at Queens' College

Mar 23, 2017

Top UK Founders provide inspiration to the next generation

Owlstone Medical Opens New Breath Biopsy Lab

Mar 20, 2017

Tony Blair officially opened the new high volume lab in Cambridge last week

Sound the Siren! Data Intelligence Company backed by Top VCs

Mar 06, 2017

Siren Solutions have won €1M of seed round funding from Ireland’s Top VCs

View all news